Lamprianidou E, et al.: Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine. Blood Adv. 2021 Jan 12;5(1):129-142. doi: 10.1182/bloodadvances.2020002351. PMID: 33570632
Lamprianidou E, et al.: Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine. Blood Adv. 2021 Jan 12;5(1):129-142. doi: 10.1182/bloodadvances.2020002351. PMID: 33570632